<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0465">
 <label>93</label>
 <mixed-citation publication-type="other" id="h0465">D. Maffei, Gilead announces results from phase 3 trial of investigational antiviral Remdesivir in patients with Severe COVID-19, Gilead Sci. Inc. (2020) 1. 
  <ext-link ext-link-type="uri" xlink:href="https://www.gilead.com/news-and-press/press-room/press-releases/2020/6/gilead-announces-results-from-phase-3-trial-of-remdesivir-in-patients-with-moderate-covid-19" id="ir030" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.gilead.com/news-and-press/press-room/press-releases/2020/6/gilead-announces-results-from-phase-3-trial-of-remdesivir-in-patients-with-moderate-covid-19</ext-link> (accessed June 20, 2020).
 </mixed-citation>
</ref>
